Search research articles
Contact Us
Filters
Showing results (151-160 of 158) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 158 results.
Neurology
|
September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
E M Frohman, D S Goodin, P A Calabresi, et al.
Journal of Neurology
|
March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
Michael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Neurology
|
November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
L J Balcer, M L Baier, J A Cohen, et al.
Neurology
|
September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL
P A Calabresi, G Giovannoni, C Confavreux, et al.
Annals of Neurology
|
August 19, 2007
Health-related quality of life in multiple sclerosis: effects of natalizumab
Richard A Rudick, Deborah Miller, Steve Hass, et al.
Neurology
|
April 18, 2007
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
L J Balcer, S L Galetta, P A Calabresi, et al.
Nature Communications
|
May 6, 2023
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
Lin Xu, Joshua L Pierce, Angelica Sanchez, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 30, 2022
Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018
S Jayaraman, L Lee, J Mata, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 158) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 158 results.
Neurology
|
September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
E M Frohman, D S Goodin, P A Calabresi, et al.
Journal of Neurology
|
March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
Michael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Neurology
|
November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
L J Balcer, M L Baier, J A Cohen, et al.
Neurology
|
September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL
P A Calabresi, G Giovannoni, C Confavreux, et al.
Annals of Neurology
|
August 19, 2007
Health-related quality of life in multiple sclerosis: effects of natalizumab
Richard A Rudick, Deborah Miller, Steve Hass, et al.
Neurology
|
April 18, 2007
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
L J Balcer, S L Galetta, P A Calabresi, et al.
Nature Communications
|
May 6, 2023
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
Lin Xu, Joshua L Pierce, Angelica Sanchez, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 30, 2022
Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018
S Jayaraman, L Lee, J Mata, et al.
Page
of 16